CEL-SCI Corp (CVM)

• Market cap: $50.8M
• 1 day: -1.85%
• 5 days: -3.05%
• 1 month: -5.64%
• 3 months: -37.95%
• 6 months: 168.35%
• Year to date: -48.92%
• 1 year: -71.25%
• 5 years: -98.5%
• 10 years: -97.91%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Employees: 44